Goldman Sachs Group Inc Maravai Lifesciences Holdings, Inc. Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
A detailed history of Goldman Sachs Group Inc transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,572,155 shares of MRVI stock, worth $5.72 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,572,155
Previous 1,362,167
15.42%
Holding current value
$5.72 Million
Previous $3.28 Million
37.48%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding MRVI
# of Institutions
183Shares Held
132MCall Options Held
688KPut Options Held
11.6K-
Gtcr LLC20.2MShares$73.3 Million6.38% of portfolio
-
12 West Capital Management LP New York, NY12.5MShares$45.6 Million4.42% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$35.4 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$30.4 Million1.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.13MShares$25.9 Million0.0% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $479M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...